FreeStyle Libre 3 – US

by Abbott Diabetes Care Inc.
500,000+ installs

Android application FreeStyle Libre 3 – US developed by is listed under category Medical. According to Google Play FreeStyle Libre 3 – US achieved more than 500,000 installs. FreeStyle Libre 3 – US currently has 3,311 ratings with average rating value of 3.37. The current percentage of ratings achieved in last 30 days is 8.02%, percentage of ratings achieved in last 60 days is 17.83%. FreeStyle Libre 3 – US has the current market position #71917 by number of ratings. A sample of the market history data for FreeStyle Libre 3 – US can be found below. Last update on 2024-08-04.

Android application info
Title:FreeStyle Libre 3 – US
Developer:
Category:Medical
Price:Free
System:Android
Rating scores
Total ratings:3311
Growth (30 days):8.02%
Growth (60 days):17.83%
Average rating:3.37
App installs
Installs (achieved):500,000+
Installs (estimated):590,617
Rating values
5 star ratings:1,374
4 star ratings:441
3 star ratings:342
2 star ratings:353
1 star ratings:795

Screenshots

screenshot of FreeStyle Libre 3 – USscreenshot of FreeStyle Libre 3 – USscreenshot of FreeStyle Libre 3 – USscreenshot of FreeStyle Libre 3 – USscreenshot of FreeStyle Libre 3 – USscreenshot of FreeStyle Libre 3 – USscreenshot of FreeStyle Libre 3 – USscreenshot of FreeStyle Libre 3 – US

Download level stats
2024-06-02: Android application FreeStyle Libre 3 – US achieved 500,000 installs.
2023-04-01: Android application FreeStyle Libre 3 – US achieved 100,000 installs.
2023-01-15: Android application FreeStyle Libre 3 – US achieved 50,000 installs.
2022-11-14: Android application FreeStyle Libre 3 – US achieved 10,000 installs.

Ratings
Number of ratings for FreeStyle Libre 3 – US.

Installs (*estimated)
Estimated number of installs on Google Play.

Average rating
Average rating value on Google Play. Given by active users of the application.

Market lead percentage
Ratings count comparing to the market leading app.

Rating distribution
Rating distribution given by active users.